ZA942257B - Pharmaceutical for the treatment of skin disorders - Google Patents

Pharmaceutical for the treatment of skin disorders

Info

Publication number
ZA942257B
ZA942257B ZA942257A ZA942257A ZA942257B ZA 942257 B ZA942257 B ZA 942257B ZA 942257 A ZA942257 A ZA 942257A ZA 942257 A ZA942257 A ZA 942257A ZA 942257 B ZA942257 B ZA 942257B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceutical
skin disorders
compound
formula
Prior art date
Application number
ZA942257A
Other languages
English (en)
Inventor
Robert Ryder Bartlett
Klaus Ulrich Weithmann
Ellen Smith Kurtz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21915403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA942257(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA942257B publication Critical patent/ZA942257B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA942257A 1993-03-31 1994-03-30 Pharmaceutical for the treatment of skin disorders ZA942257B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4122393A 1993-03-31 1993-03-31

Publications (1)

Publication Number Publication Date
ZA942257B true ZA942257B (en) 1994-11-16

Family

ID=21915403

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942257A ZA942257B (en) 1993-03-31 1994-03-30 Pharmaceutical for the treatment of skin disorders

Country Status (17)

Country Link
US (1) US5504084A (de)
EP (1) EP0617959B1 (de)
JP (1) JP2930281B2 (de)
KR (1) KR100310665B1 (de)
AT (1) ATE183088T1 (de)
AU (1) AU670491B2 (de)
CA (1) CA2120319C (de)
CY (1) CY2207B1 (de)
DE (1) DE69419954T2 (de)
DK (1) DK0617959T3 (de)
ES (1) ES2135500T3 (de)
GR (1) GR3031264T3 (de)
HU (1) HU216194B (de)
IL (1) IL109151A (de)
RU (1) RU2151597C1 (de)
TW (1) TW314467B (de)
ZA (1) ZA942257B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2202904C (en) * 1994-10-17 2006-12-19 Yukio Amano Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
ES2150808T3 (es) * 1997-08-08 2000-12-01 Aventis Pharma Gmbh Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
CA2443285C (en) 2001-04-05 2007-08-21 Aventis Pharmaceuticals Inc. Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
WO2005011669A1 (ja) * 2003-08-05 2005-02-10 Dainippon Sumitomo Pharma Co., Ltd. 経皮投与用医薬組成物
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2006082834A1 (ja) * 2005-02-02 2006-08-10 Kowa Co., Ltd. ケラチノサイト増殖に起因する疾患の予防・治療剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3035670A1 (de) * 1980-09-22 1982-04-29 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zur infusion von fluessigkeiten in den menschlichen oder tierischen koerper
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
DE3927257A1 (de) * 1989-08-18 1991-02-21 Hoechst Ag Verfahren zur herstellung eines polyolefins
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5494911A (en) * 1990-05-18 1996-02-27 Hoechst Aktiengesellschaft Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them
DE4227594A1 (de) * 1992-08-20 1994-02-24 Wacker Chemie Gmbh Synthetische Alumosilikate und ihre Verwendung als heterogene Äquilibrierungskatalysatoren

Also Published As

Publication number Publication date
JP2930281B2 (ja) 1999-08-03
CA2120319C (en) 2009-01-06
ES2135500T3 (es) 1999-11-01
HU216194B (hu) 1999-05-28
DE69419954T2 (de) 2000-04-13
JPH06329538A (ja) 1994-11-29
HU9400908D0 (en) 1994-06-28
AU670491C (en) 1994-10-06
GR3031264T3 (en) 1999-12-31
TW314467B (de) 1997-09-01
AU5915794A (en) 1994-10-06
DK0617959T3 (da) 2000-01-24
CY2207B1 (en) 2002-11-08
KR940021060A (ko) 1994-10-17
AU670491B2 (en) 1996-07-18
IL109151A0 (en) 1994-06-24
IL109151A (en) 1998-12-27
DE69419954D1 (de) 1999-09-16
KR100310665B1 (ko) 2001-12-28
US5504084A (en) 1996-04-02
EP0617959B1 (de) 1999-08-11
HUT70757A (en) 1995-10-30
EP0617959A1 (de) 1994-10-05
ATE183088T1 (de) 1999-08-15
CA2120319A1 (en) 1994-10-01
RU2151597C1 (ru) 2000-06-27

Similar Documents

Publication Publication Date Title
HU9600834D0 (en) Quinazoline derivatives
HK1005425A1 (en) Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis
AU5752194A (en) Benzimidazole compounds, their use and preparation
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
GR3035526T3 (en) Retroviral protease inhibitors.
HU910681D0 (en) Medical solution
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
EP0773022A3 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
GB9305295D0 (en) Therapeutic compounds
IE880061L (en) 1,2,4,5-tetrasubstituted benzene derivatives
GB9310095D0 (en) Therapeutic compounds
AU670491C (en) Pharmaceutical for the treatment of skin disorders
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
AU7777794A (en) Melatonin derivatives for use in treating sleep disorders
GR3031267T3 (en) Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals.
EP0535250A4 (en) Novel compounds and use thereof as medicine
HU9203052D0 (en) Method for treatment of hypertension
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
HK1007857A1 (en) New compound leustroducsin H its preparation and its therapeutic use
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.